Global Outlook on the Next Generation Sequencers (NGS) Market to 2022: Strategic Business Report 2018 - Growing Significance of NGS in Enabling Personalized Oncology

DUBLIN, July 12, 2018 /PRNewswire/ --

The "Next Generation Sequencers - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand.

The global market is additionally analyzed by the following End-Use Segments:

• Pharmaceutical/Biotech
• Industrial
• Government/Academia

The report profiles 93 companies including many key and niche players such as:

• Agilent Technologies Inc. (US)
• Becton, Dickinson and Company (BD) (US)
• Fluidigm Corporation (US)
• Genomatix GmbH (Germany)
• Illumina, Inc. (US)
• Oxford Gene Technology (UK)
• Oxford Nanopore Technologies (UK)
• Pacific Biosciences of California, Inc. (US)
• QIAGEN N.V. (The Netherlands)
• RainDance Technologies, Inc. (US)
• Roche Sequencing (US)
• Shenzhen BGI Diagnosis Co., Ltd. (China)
• Thermo Fisher Scientific, Inc. (US)

Key Topics Covered

1. OVERVIEW
Next Generation Sequencing Techniques Transform the Genomics Space
Next Generation Sequencers (NGS): A High-Throughput Sequencing Technology
US Leads the NGS Market, Asia-Pacific to Foster Future Growth
Academic & Research Dominates NGS Market
Oncology Testing
The Application with Most Promising Opportunities for NGS Technology
Declining Cost of Sequencing to Fuel Adoption of NGS Systems
After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption?

2. COMPETITIVE LANDSCAPE
A Highly Competitive Marketplace
Illumina Leads the Global NGS Market
Illumina's NGS Instruments Portfolio
A Comparison
A Glance at the Major NGS Platforms in Use
Key NGS Platforms on the Market

3. GROWTH DRIVERS, MARKET TRENDS & ISSUES
Expanding Applications of NGS Technology
NGS Revolutionizes Drug Discovery and Development Space
Genetic Information offered by NGS Aids in Drug Development Process
Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of Precision Medicine
Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS Market
Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation Sequencing Methods for Identification of Driver Mutations
Key Cancer Statistics
NGS Emerges as a Game Changing Technology for Precision Oncology
Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to Patients
Growing Significance of NGS in Enabling Personalized Oncology
Timeline of Major Developments in Sequencing Technologies & Applications Related to Oncology
Personal Genomics Services
Blessing or Bane?
NGS Technology Drives RNA Sequencing in Transcriptomics
Longer Reach of a Read: A Key Feature Considered for Sequencing
qPCR
The Core Technique in NGS Technique
Development of New Systems & Platforms to Fuel NGS Utilization
Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption
Development Efforts Intensify in Long-Read Sequencing
Single-Cell Genomics: A Promising Application of NGS Technology
Shift from Tumor Biopsies to Cancer Liquid Biopsies
NGS Enhances Study of Antimicrobial Resistance
Effective Use of NGS Tools in Public Healthcare Systems
E-Infrastructure for Storage & Analysis of NGS Data
Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing
NGS Hold an Edge Over CE Sequencing Method
Standardization of NGS Technique: A Critical Requirement for Wider Adoption
Challenges Confronting High-throughput Sequencing Market
High Machine Costs and Licensure Fees
Lack of Skilled Personnel
Absence of Regulatory Framework
Limited Access to Scientific Literature and Internet
Suboptimal Outsourcing Services
Regulations Related to NGS-Based Tests
Innovative Technologies
Nanopore Sequence Technology
Single-Molecule Real-Time technology (SMRT)
Direct Genomics' Single Molecule Sequencing
TruSPADES Simplifies Metagenomics Sequencing
GnuBIO Platform
Electron Microscopy DNA Sequencing
FRET-based DNA Sequencing
Identification/Sequencing using Mechanical Properties
MALDI-TOF MS
RNAP Sequencing Method
Tunneling Currents DNA Sequencing
qPCR-Driven Library Quantitation Saves Time and Overheads
Achieving Trans-Block Uniformity
Enhancing qPCR Precision

4. TECHNOLOGY OVERVIEW

5. PRODUCT INNOVATIONS/INTRODUCTIONS
QIAGEN Launches Novel QIAseq NGS Panels
BD Launches BD CLiC System
Immucor and Sirona Genomics Launch MIA FORA NGS
bioMrieux and Illumina Launch bioMrieux EpiSeq NGS Service
Bioline Introduces JetSeq Kit for NGS Sample Preparation
Oxford Gene Technology Launches SureSeq NGS Solutions
GENEWIZ Launches FuzeSeq Antibody Sequencing Technology
Sage Science Launches PippinHT Automated Instruments for Use with NGS
BGI Tech to Launch Two Ranges of NGS
X Bio and Intelligen
Thermo Fisher Scientific Introduces Clinical NGS Oncology Quality Control
Vela Diagnostics Announces Pre-launch of Automated NGS
Rubicon Genomics Launches PicoPLEX DNA-seq Kits for Use with NGS Platforms

6. RECENT INDUSTRY ACTIVITY
Mayo Clinic Collaborates with Illumina on NGS
Sophia Genetics Enters into Partnership with Illumina
Novogene Enters into Collaboration with AITbiotech
Natera Extends Supply Agreement with Illumina
ArcherDX Enters into Collaboration with Illumina
TBUSH to Acquire WaferGen Bio-systems
Advanced Biological Laboratories Signs Distribution Agreement with Thermo Fisher Scientific
Bio-Rad Enters into Partnership with Illumina
SYGNIS AG Signs Distribution Agreement with Lucigen
Almac Diagnostics Enters into Collaboration with Illumina
Roche Acquires Kapa Biosystems
QIAGEN Expands Partnership with BGI
Intel Enters into Partnership with Edico Genome
Illumina Enters into Partnership with Merck Serono
Lockheed Martin and Illumina Enter into Partnership
WuXi PharmaTech Acquires NextCODE Health
Roche Acquires Bina Technologies
CollabRx Enters into Partnership with Cartagenia
New England Biolabs and Directed Genomics Enter into Partnership
Reprogenetics Partners with Illumina
BD Acquires GenCell Biosystems
AB SCIEX and Illumina Enter into OneOmics Partnership Project
Thermo Fisher Scientific, GSK, and Pfizer Enter into Agreement to Develop NGS
AstraZeneca Collaborates with Illumina
Roche Acquires Genia Technologies

7. FOCUS ON SELECT GLOBAL PLAYERS
Agilent Technologies Inc. (US)
Becton, Dickinson and Company (BD) (US)
Fluidigm Corporation (US)
Genomatix GmbH (Germany)
Illumina, Inc. (US)
Oxford Gene Technology (UK)
Oxford Nanopore Technologies (UK)
Pacific Biosciences of California, Inc. (US)
QIAGEN N.V. (The Netherlands)
RainDance Technologies, Inc. (US)
Roche Sequencing (US)
Shenzhen BGI Diagnosis Co., Ltd. (China)
Thermo Fisher Scientific, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE
 
Total Companies Profiled: 93 (including Divisions/Subsidiaries 104)

• The United States (61)
• Canada (3)
• Japan (2)
• Europe (27)
• France (1)
• Germany (7)
• The United Kingdom (5)
• Rest of Europe (14)
• Asia-Pacific (Excluding Japan) (11)

For more information about this report visit https://www.researchandmarkets.com/research/2cr8zz/global_outlook_on?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com